The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.


Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 02 2021
revised: 29 04 2021
accepted: 01 06 2021
pubmed: 8 6 2021
medline: 6 10 2021
entrez: 7 6 2021
Statut: ppublish

Résumé

Inflammation has a major role in diabetic kidney disease. We thus investigated the role of the IL-8-CXCR1/2 axis in favoring kidney damage in diabetes. Urinary IL-8 levels were measured in 1247 patients of the Joslin Kidney Study in type 2 diabetes (T2D). The expression of IL-8 and of its membrane receptors CXCR1/CXCR2 was quantified in kidney tissues in patients with T2D and in controls. The effect of CXCR1/2 blockade on diabetic kidney disease was evaluated in db/db mice. IL-8 urinary levels were increased in patients with T2D and diabetic kidney disease, with the highest urinary IL-8 levels found in the patients with the largest decline in glomerular filtration rate, with an increased albumin/creatine ratio and the worst renal outcome. Moreover, glomerular IL-8 renal expression was increased in patients with T2D, as compared to controls. High glucose elicits abundant IL-8 secretion in cultured human immortalized podocytes in vitro. Finally, in diabetic db/db mice and in podocytes in vitro, CXCR1/2 blockade mitigated albuminuria, reduced mesangial expansion, decreased podocyte apoptosis and reduced DNA damage. The IL-8- CXCR1/2 axis may have a role in diabetic kidney disease by inducing podocyte damage. Indeed, targeting the IL-8-CXCR1/2 axis may reduce the burden of diabetic kidney disease.

Identifiants

pubmed: 34097917
pii: S0026-0495(21)00104-9
doi: 10.1016/j.metabol.2021.154804
pii:
doi:

Substances chimiques

Interleukin-8 0
Receptors, CXCR 0
Receptors, Interleukin-8A 0
Receptors, Interleukin-8B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154804

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Cristian Loretelli (C)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Francesca Rocchio (F)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Francesca D'Addio (F)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Moufida Ben Nasr (M)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Eduardo Castillo-Leon (E)

Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Sergio Dellepiane (S)

Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Andrea Vergani (A)

Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Ahmed Abdelsalam (A)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy; Department of Biochemistry and Biotechnology, Heliopolis University, Cairo, Egypt.

Emma Assi (E)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Anna Maestroni (A)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Vera Usuelli (V)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Roberto Bassi (R)

Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Ida Pastore (I)

Endocrinology Division, ASST Fatebenefratelli Sacco, Milan, Italy.

Jun Yang (J)

Institute of Organ Transplantation, Tongji Hospital and Medical College, Huazhong University of Science and Technology, Wuhan, China.

Basset El Essawy (B)

Medicine, Al-Azhar University, Cairo, Egypt; Transplantation Research Center, Nephrology Division, Brigham and Women's Hospital, Boston, MA, USA.

Khalid M Elased (KM)

Department of Pharmacology & Toxicology Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.

Gian Paolo Fadini (GP)

Department of Medicine, University of Padua, Padua, Italy.

Elio Ippolito (E)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Andy Joe Seelam (AJ)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy.

Marcus Pezzolesi (M)

Division of Nephrology & Hypertension and Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, UT, USA.

Domenico Corradi (D)

Pathology and Laboratory Medicine, University of Parma, Parma, Italy.

Gian Vincenzo Zuccotti (GV)

Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano and Dipartimento di Pediatria, Ospedale dei Bambini Buzzi, Milan, Italy.

Maurizio Gallieni (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy; Nephrology and Dialysis Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.

Marcello Allegretti (M)

Dompé Farmaceutici SpA, L'Aquila, Italy.

Monika Anna Niewczas (MA)

Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA, USA.

Paolo Fiorina (P)

International Center for T1D, Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università di Milano, Milan, Italy; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Endocrinology Division, ASST Fatebenefratelli Sacco, Milan, Italy. Electronic address: paolo.fiorina@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH